Nephrology News
SABR for Renal Cell Carcinoma Offers Excellent Outcomes
Stereotactic ablative radiotherapy is associated with high 2- and 4-year rates of local cancer control and progression-free and cancer-specific survival.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/